Buscar resultados de ensayos clínicos
Hemolytic-Uremic Syndrome - 25 Studies Found
Estado | Estudiar |
Terminated |
Nombre del estudio: aHUS Observational Long Term Follow-Up Condición: Atypical Hemolytic Uremic Syndrome Fecha: 2012-01-18 |
Recruiting |
Nombre del estudio: Study of 'Vascular Competence' Profile and Endothelial Activation in the Hemolytic Uremic Syndrome in Children and Adults Condición: Hemolytic Uremic Syndrome Fecha: 2016-09-08 Intervenciones: Biological: Extra blood draw samples |
Terminated |
Nombre del estudio: Complement Inhibition in aHUS Dialysis Patients Condición: Atypical Hemolytic Uremic Syndrome Fecha: 2015-05-26 Intervenciones: Drug: CCX168 |
Completed |
Nombre del estudio: Open Label Controlled Trial of Eculizumab in Adult Patients With Plasma Therapy-Resistant aHUS Condición: Atypical Hemolytic Uremic Syndrome Fecha: 2009-02-13 Intervenciones: Drug: Eculizumab All patients received open-label eculizumab administered intravenously on the following |
Completed |
Nombre del estudio: Open Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Resistant aHUS Condición: Atypical Hemolytic Uremic Syndrome Fecha: 2009-02-13 Intervenciones: Drug: Eculizumab All patients received open-label eculizumab administered intravenously on the following |
Completed |
Nombre del estudio: Open Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Sensitive aHUS Condición: Atypical Hemolytic Uremic Syndrome Fecha: 2009-02-12 Intervenciones: Drug: eculizumab All patients received open-label eculizumab administered intravenously on the following |
Completed |
Nombre del estudio: The Safety and Efficacy of Eculizumab in Japanese Patients With Atypical Hemolytic Uremic Syndrome (aHUS) Condición: Atypical Hemolytic Uremic Syndrome (aHUS) Fecha: 2012-12-04 Intervenciones: Drug: Eculizumab |
Recruiting |
Nombre del estudio: Single Arm Study of ALXN1210 in Complement Inhibitor Treatment-Naïve Adult and Adolescent Patients With Atypical Hemolytic Uremic Syndrome (aHUS) Condición: Atypical Hemolytic Uremic Syndrome (aHUS) Fecha: 2016-10-25 Intervenciones: Biological: ALXN1210 Single loading dose on Day 1, followe |
Completed |
Nombre del estudio: To Characterize the Safety and Tolerability of Eculizumab in Two Japanese aHUS Patients Condición: ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS) Fecha: 2012-12-04 |
Enrolling by invitation |
Nombre del estudio: Eval. of Potential Predictors of Disease Progression in Patients With aHUS Including Genetics, Biomarkers and Treatment Condición: Atypical Hemolytic Uremic Syndrome Fecha: 2015-11-24 Intervenciones: Other: Clinical assessments and laboratory tests. Clinical assessments and laboratory tests required at |